monoclonal antibodies (inflammatory disease)

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

IL-21 antagonists
申请人: ZYMOGENETICS INC优先权: 2005
EP
US
8 件公开
MONOCLONAL ANTIBODIES SPECIFIC FOR PATHOLOGICAL AMYLOID AGGREGATES COMMON TO AMYLOIDS FORMED FROM PROTEINS OF DIFFERING SEQUENCE
申请人: UNIV CALIFORNIA优先权: 2009
US
Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
申请人: UNIV CALIFORNIA优先权: 2004
US
Type XXIII collagen assay
申请人: NORDIC BIOSCIENCE AS优先权: 2019
US
KIR3DL2 binding agents
申请人: INNATE PHARMA优先权: 2013
US
KIR3DL2 binding agents
申请人: INNATE PHARMA优先权: 2015
US
2 件公开
ANTI-CD132 ANTIBODIES, AND USE THEREOF
申请人: INST OF DERMATOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES AND PEKING UNION MEDICAL COLLEGE优先权: 2024
WO
SH3YL1 ANTIBODIES, COMPOSITIONS COMPRISING THE SAME, AND VECTORS AND USES THEREOF
申请人: CELROS BIOTECH优先权: 2020
EP
US
WO
7 件公开